## Review setup
- **Input scope** Abstract only
- **Assessment boundary** Claims and evidence presented in the abstract; no methods, figures, tables, or supplementary material were provided
- **Shared manuscript claim summary** The authors present prosECCo75, a CHARMM36-based force field with charge scaling to effectively incorporate electronic polarization, and claim improved accuracy for ion interactions with lipids, proteins, and saccharides without compromising biomolecular structure, at no additional computational cost
- **Visible evidence base** Abstract text only; no quantitative data, methodological details, or validation results are available
- **Missing materials affecting confidence** Full manuscript, methods section, all figures and tables, simulation protocols, experimental comparison datasets, and any statistical analyses

## Reviewer
- **Overall assessment** The abstract describes a potentially valuable approach to improving electrostatic interactions in biomolecular simulations through charge scaling within the CHARMM36 framework. The concept of effectively incorporating electronic polarization without added computational cost is attractive and aligns with ongoing efforts in the field. However, the abstract provides no quantitative evidence, no methodological specifics, and no comparative benchmarks. The claims of improved accuracy and broad applicability are stated but not substantiated. The scientific case cannot be evaluated from the supplied material, and the abstract alone does not establish the validity or utility of prosECCo75.
- **Who would be interested in the results, and why** Computational biophysicists and molecular dynamics practitioners studying ion interactions with membranes, proteins, and carbohydrates would be interested. Researchers developing or refining biomolecular force fields, particularly those seeking cost-effective alternatives to explicitly polarizable models, would also find the approach relevant. The potential to improve accuracy in nominally nonpolarizable simulations without added computational expense is broadly appealing to the molecular simulation community.
- **Major strengths** The conceptual approach of using charge scaling to effectively incorporate electronic polarization is physically motivated and addresses a known limitation of nonpolarizable force fields. The claim of no additional computational cost is practically significant. The scope of target systems, including lipids, proteins, and saccharides, suggests potential broad applicability.
- **Major Concerns**  
  - **Concern ID** R1-M1  
  - **Severity** Major  
  - **Blocking** Yes  
  - **Axis** Evidence sufficiency  
  - **Claim pointer** The abstract claims that prosECCo75 "improves agreement with experimental ion binding data across a broad spectrum of systems" and "does not compromise biomolecular structures"  
  - **Evidence pointer** Abstract only; location not provided  
  - **Concern** No quantitative results, comparisons, or statistical measures are presented to support the claimed improvements. The abstract states outcomes without showing data.  
  - **Why it matters** The central claims of the work are accuracy improvements and structural preservation. Without visible evidence, these claims are unverifiable and the scientific contribution cannot be assessed.  
  - **Resolution test** Provide quantitative comparisons against experimental data and against the parent CHARMM36 force field, including error metrics, for each system class. Show structural validation data, such as RMSD or other relevant measures, demonstrating no compromise.
  
  - **Concern ID** R1-M2  
  - **Severity** Major  
  - **Blocking** Yes  
  - **Axis** Methodological transparency  
  - **Claim pointer** The abstract states that charge scaling is applied "within the CHARMM36 framework" and accounts for electronic polarizability "in a physical rigorous mean-field way"  
  - **Evidence pointer** Abstract only; location not provided  
  - **Concern** The specific scaling factors, the derivation of those factors, and the physical justification for the mean-field treatment are not described. The abstract does not explain how the scaling was optimized or validated.  
  - **Why it matters** Reproducibility and physical rigor are essential for a force field parameterization. Without methodological detail, the approach cannot be evaluated or replicated by others.  
  - **Resolution test** Provide a full description of the charge scaling procedure, including the physical basis, the optimization target, and the validation protocol. Include the final parameter set and any sensitivity analyses.
  
  - **Concern ID** R1-M3  
  - **Severity** Major  
  - **Blocking** Yes  
  - **Axis** Scope of validation  
  - **Claim pointer** The abstract claims "broader applicability" and improved accuracy "across a broad spectrum of systems"  
  - **Evidence pointer** Abstract only; location not provided  
  - **Concern** The abstract does not specify which ions, which lipid types, which proteins or peptides, or which saccharides were tested. The breadth of the claim cannot be assessed without knowing the coverage of the validation set.  
  - **Why it matters** Overgeneralization from limited test systems is a common failure mode in force field development. The claim of broad applicability requires demonstration across diverse chemical environments.  
  - **Resolution test** List all tested systems, including ion types, lipid headgroups, protein and peptide sequences, and saccharide chemistries. Show that the validation set is representative of the claimed scope.
- **Minor Comments**  
  - **Concern ID** R1-m1  
  - **Severity** Minor  
  - **Axis** Clarity  
  - **Affected element** Terminology  
  - **Evidence pointer** Abstract; location not provided  
  - **Issue** The phrase "physical rigorous mean-field way" is vague and could be misinterpreted.  
  - **Required correction** Clarify the physical model, for example by specifying the relationship to continuum dielectric treatments or explicit polarizability models.
  
  - **Concern ID** R1-m2  
  - **Severity** Minor  
  - **Axis** Completeness  
  - **Affected element** Performance claim  
  - **Evidence pointer** Abstract; location not provided  
  - **Issue** The claim of "no added computational costs" is stated without any benchmark data.  
  - **Required correction** Provide a brief performance comparison, such as simulation speed relative to standard CHARMM36, to substantiate the claim.
  
  - **Concern ID** R1-m3  
  - **Severity** Minor  
  - **Axis** Scope  
  - **Affected element** System coverage  
  - **Evidence pointer** Abstract; location not provided  
  - **Issue** The abstract mentions "saccharides" but does not indicate whether this includes monosaccharides, oligosaccharides, or polysaccharides.  
  - **Required correction** Specify the saccharide types studied to avoid ambiguity.
- **Technical failings that need to be addressed before the case is established** R1-M1, R1-M2, R1-M3. The abstract provides no quantitative evidence, no methodological detail, and no defined validation scope. The core claims of improved accuracy, physical rigor, and broad applicability are currently unsupported.
- **Assessment against Nature-style criteria**  
  - Originality: The charge scaling approach is not entirely new, but its systematic application across multiple biomolecular classes within CHARMM36 may offer a novel contribution. The abstract does not clearly differentiate from prior charge scaling efforts.  
  - Scientific importance: Improving electrostatic accuracy in nonpolarizable simulations is important for the field. The potential for broad applicability is significant, but the importance is not yet demonstrated.  
  - Interdisciplinary readership: The work could appeal to researchers in biophysics, chemistry, and structural biology. The abstract is written in a way that is accessible to nonspecialists, though technical terms such as "charge scaling" and "mean-field" are used without definition.  
  - Technical soundness: Cannot be assessed from the abstract. No methodological or validation details are provided.  
  - Readability for nonspecialists: The abstract is generally readable, but the lack of context for key terms and the absence of concrete results limit its accessibility.
- **Recommendation posture** Currently not established from the provided evidence. The abstract presents a promising concept but does not provide the data or methodological detail necessary to evaluate the claims. A full manuscript with quantitative validation and complete methodological description would be required to assess the work.

## Risk / unsupported claims
- The claim of improved agreement with experimental ion binding data is unsupported, as no data are shown.
- The claim that biomolecular structures are not compromised is unsupported, as no structural validation is presented.
- The claim of "physical rigorous" mean-field treatment is unverifiable without methodological detail.
- The claim of "no added computational costs" is unsubstantiated without benchmark data.
- The claim of "broader applicability" is unverifiable without a defined and demonstrated validation scope.